Bagnoud, M.; Briner, M.; Remlinger, J.; Meli, I.; Schuetz, S.; Pistor, M.; Salmen, A.; Chan, A.; Hoepner, R.
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells 2020, 9, 2154.
https://doi.org/10.3390/cells9102154
AMA Style
Bagnoud M, Briner M, Remlinger J, Meli I, Schuetz S, Pistor M, Salmen A, Chan A, Hoepner R.
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells. 2020; 9(10):2154.
https://doi.org/10.3390/cells9102154
Chicago/Turabian Style
Bagnoud, Maud, Myriam Briner, Jana Remlinger, Ivo Meli, Sara Schuetz, Maximilian Pistor, Anke Salmen, Andrew Chan, and Robert Hoepner.
2020. "c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis" Cells 9, no. 10: 2154.
https://doi.org/10.3390/cells9102154
APA Style
Bagnoud, M., Briner, M., Remlinger, J., Meli, I., Schuetz, S., Pistor, M., Salmen, A., Chan, A., & Hoepner, R.
(2020). c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells, 9(10), 2154.
https://doi.org/10.3390/cells9102154